Jazz Pharmaceuticals plc buy Morgan Stanley
Start price
07.03.25
/
50%
€128.00
Target price
07.03.26
€168.73
Performance (%)
-12.50%
Price
20:02
€112.00
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -12.50%. This prediction currently runs until 07.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 1.817% | 1.817% |
| iShares Core DAX® | -0.940% | 2.343% |
| iShares Nasdaq 100 | -0.726% | 1.863% |
| iShares Nikkei 225® | -0.767% | 4.952% |
| iShares S&P 500 | -0.345% | 2.613% |
Comments by Morgan_Stanley for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Morgan_Stanley for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€92.16
06.08.25
06.08.25
€140.03
06.08.26
06.08.26
21.53%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€99.04
22.07.25
22.07.25
€141.14
22.07.26
22.07.26
13.09%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€90.20
07.05.25
07.05.25
€146.33
07.05.26
07.05.26
24.17%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€120.35
12.12.24
12.12.24
€167.02
12.12.25
12.12.25
-6.94%
20:02
20:02